CYBIN INC. — Investor Relations & Filings
Cybin Inc. is a late-stage clinical neuropsychiatry company dedicated to revolutionizing mental healthcare by developing novel psychedelic-based therapeutics. The company utilizes proprietary drug discovery platforms, innovative drug delivery systems, and a deuterated chemical process to engineer next-generation, patent-protected drug candidates from tryptamine-based scaffolds. Its lead programs include CYB003, a deuterated psilocybin analog for Major Depressive Disorder (MDD) that has received FDA Breakthrough Therapy Designation, and CYB004 for the treatment of Generalized Anxiety Disorder (GAD). Cybin aims to create safer, more effective, and commercially scalable treatments for various mental health conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | |
| 6-K Filing | 2026-02-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38139607 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | ||
| 35894872 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | ||
| 34694400 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34693984 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34648069 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | ||
| 31978132 | 6-K Filing | 2026-02-18 | English | ||
| 31978135 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31978134 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31978131 | 6-K Filing | 2026-02-17 | English | ||
| 31978136 | 6-K Filing | 2026-02-13 | English | ||
| 31978133 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31978137 | 6-K Filing | 2026-02-10 | English | ||
| 13343163 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 13343166 | 6-K | 2026-01-05 | English | ||
| 13343164 | Regulatory Filings 2026 | 2026-01-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
CYBIN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33911/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33911 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33911 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33911 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33911}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CYBIN INC. (id: 33911)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.